FCG Investment Company’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-3,025	Closed	-$1.42M	–	122
2024 Q2	$1.42M	Buy	3,025 +715	+31%	+$335K	1.08%	20
2024 Q1	$966K	Sell	2,310 -1,065	-32%	-$445K	0.77%	43
2023 Q4	$1.37M	Buy	+3,375	New	+$1.37M	1.35%	25